We first assessed the expression of TGFβ2 in multiple tumour and normal tissue types using the Oncomine database, revealing that expression of this gene was elevated relative to normal tissue controls for brain, breast, colorectal, oesophageal, rectal, gastric, head and neck, liver, renal and pancreatic cancers. The gene discussed is TGFB2; the disease is neoplasm.